GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Imexpharm Corp (STC:IMP) » Definitions » Cyclically Adjusted Book per Share

Imexpharm (STC:IMP) Cyclically Adjusted Book per Share : ₫26,247.10 (As of Mar. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Imexpharm Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Imexpharm's adjusted book value per share for the three months ended in Mar. 2024 was ₫30,662.259. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₫26,247.10 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Imexpharm's average Cyclically Adjusted Book Growth Rate was 6.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2024-06-07), Imexpharm's current stock price is ₫69300.00. Imexpharm's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was ₫26,247.10. Imexpharm's Cyclically Adjusted PB Ratio of today is 2.64.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Imexpharm was 3.50. The lowest was 1.81. And the median was 2.55.


Imexpharm Cyclically Adjusted Book per Share Historical Data

The historical data trend for Imexpharm's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Imexpharm Cyclically Adjusted Book per Share Chart

Imexpharm Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 22,303.70 24,191.90 25,558.00

Imexpharm Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24,694.20 25,031.60 25,427.50 25,558.00 26,247.10

Competitive Comparison of Imexpharm's Cyclically Adjusted Book per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Imexpharm's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Imexpharm's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Imexpharm's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Imexpharm's Cyclically Adjusted PB Ratio falls into.



Imexpharm Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Imexpharm's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=30662.259/131.7762*131.7762
=30,662.259

Current CPI (Mar. 2024) = 131.7762.

Imexpharm Quarterly Data

Book Value per Share CPI Adj_Book
201406 16,453.450 100.560 21,561.097
201409 16,848.473 100.428 22,107.701
201412 16,463.275 99.070 21,898.399
201503 17,050.576 99.621 22,554.058
201506 16,437.201 100.684 21,513.190
201509 16,767.561 100.392 22,009.488
201512 17,036.857 99.792 22,497.227
201603 17,435.733 100.470 22,868.573
201606 16,636.479 101.688 21,558.983
201609 17,069.799 101.861 22,082.968
201612 18,450.137 101.863 23,868.295
201703 19,925.606 102.862 25,526.585
201706 19,947.599 103.349 25,434.366
201709 20,273.400 104.136 25,654.547
201712 20,378.089 104.011 25,817.890
201803 20,683.012 105.290 25,886.045
201806 21,087.570 106.317 26,137.354
201809 21,603.762 106.507 26,729.414
201812 21,975.991 105.998 27,320.471
201903 22,505.147 107.251 27,651.552
201906 21,477.607 108.070 26,189.049
201909 22,023.942 108.329 26,790.801
201912 22,773.832 108.420 27,679.822
202003 23,374.470 108.902 28,284.265
202006 23,178.232 108.767 28,081.412
202009 24,217.929 109.815 29,061.144
202012 24,719.430 109.897 29,640.832
202103 25,317.322 111.754 29,853.147
202106 24,233.880 114.631 27,858.411
202109 24,681.261 115.734 28,102.324
202112 25,632.562 117.630 28,715.259
202203 26,383.954 121.301 28,662.395
202206 25,285.586 125.017 26,652.725
202209 26,082.522 125.227 27,446.712
202212 27,061.555 125.222 28,478.020
202303 28,173.279 127.348 29,152.978
202306 27,748.331 128.729 28,405.240
202309 28,744.042 129.860 29,168.298
202312 29,777.742 129.419 30,320.011
202403 30,662.259 131.776 30,662.259

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Imexpharm  (STC:IMP) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Imexpharm's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=69300.00/26247.1
=2.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Imexpharm was 3.50. The lowest was 1.81. And the median was 2.55.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Imexpharm Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Imexpharm's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Imexpharm (STC:IMP) Business Description

Industry
Traded in Other Exchanges
N/A
Address
4 Road 30/04 Street Ward 1, Cao Lanh City, Dongthap, VNM
Imexpharm Corp is engaged in the manufacture, import, export, and trade of pharmaceuticals and medicinal chemical products. Its products include oral and injective antibiotic, digestion, central nervous system, cardiovascular, diabetes, musculoskeletal system, respiratory system, analgesic-anti-inflammatory, anti-allergy, ophthalmology, external drugs, and anti-parasitic, as well as vitamins and minerals.

Imexpharm (STC:IMP) Headlines

No Headlines